Literature DB >> 2821053

Age-related changes in serum immunoreactive parathyroid hormone and its biological action in healthy men and women.

D B Endres1, C H Morgan, P J Garry, J L Omdahl.   

Abstract

Circulating levels of PTH and related parameters of calcium and phosphate metabolism were measured in healthy free-living elderly and young subjects residing in the Southwest to determine if parathyroid function changes with aging. Serum immunoreactive PTH (iPTH) was measured with two well characterized antisera; an amino (N)-terminal antiserum which cross-reacts with the biologically active domain (1-34) and recognizes intact hormone, and a midregion (44-68) antiserum which cross-reacts with intact hormone and biologically inactive midregion/C-terminal fragments. Serum iPTH in both RIAs was significantly increased in the elderly population. An age-related increase was also found for total urinary cAMP and serum alkaline phosphatase, whereas the tubular reabsorptive maximum for phosphate (TmP/GFR) decreased with age. No difference was found between men and women of the same age group for serum iPTH, urinary cAMP, or serum alkaline phosphatase. TmP/GFR declined with age in men, but not women. Correspondingly, serum phosphate was significantly lower in elderly men than in elderly women. Urinary calcium excretion was higher in elderly women than in men of the same age group. Neither serum total or ionized calcium decreased with age. In conclusion, the age-related increase in N-terminal PTH and alterations in associated parameters of phosphate and calcium metabolism are consistent with increased parathyroid function as men and women age. Factors other than PTH are responsible for the sex-related differences observed in TmP/GFR, calcium excretion, and serum phosphate. The cause of the increased circulating levels of apparently biologically active PTH is unclear, but extends beyond the age-related decrease in renal function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821053     DOI: 10.1210/jcem-65-4-724

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey.

Authors:  J M Paik; W R Farwell; E N Taylor
Journal:  Osteoporos Int       Date:  2011-09-20       Impact factor: 4.507

Review 2.  Vitamin D insufficiency as a determinant of hip fractures.

Authors:  J M Quesada-Gómez; J Alonso; R Bouillon
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 3.  Bone loss in men.

Authors:  C Gennari; R Nuti
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

4.  Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects.

Authors:  L Maïmoun; D Simar; D Malatesta; C Caillaud; E Peruchon; I Couret; M Rossi; D Mariano-Goulart
Journal:  Br J Sports Med       Date:  2005-08       Impact factor: 13.800

Review 5.  Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

6.  Absence of hyperparathyroidism in severe liver disease.

Authors:  G L Klein; D B Endres; J D Colonna; W E Berquist; L I Goldstein; R W Busuttil; L J Deftos
Journal:  Calcif Tissue Int       Date:  1989-05       Impact factor: 4.333

7.  Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure, and vitamin D.

Authors:  K Landin-Wilhelmsen; L Wilhelmsen; G Lappas; T Rosén; G Lindstedt; P A Lundberg; J Wilske; B A Bengtsson
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

8.  Primary hyperparathyroidism in older people: surgical treatment with minimally invasive approaches and outcome.

Authors:  Chiara Dobrinja; Marta Silvestri; Nicolò de Manzini
Journal:  Int J Endocrinol       Date:  2012-06-12       Impact factor: 3.257

9.  Vitamin D and bone mineral density.

Authors:  D Collins; C Jasani; I Fogelman; R Swaminathan
Journal:  Osteoporos Int       Date:  1998       Impact factor: 5.071

Review 10.  Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management.

Authors:  P R Ebeling
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 4.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.